Seismic velocity variations on the San Andreas fault caused by the 2004 M6 Parkfield Earthquake and their implications
スポンサーリンク
概要
- 論文の詳細を見る
- Terra Scientific Pub. Co.の論文
- 2007-01-01
著者
-
Li Yong-gang
Department Of Virology Research Institute For Microbial Diseases Osaka University
-
Li Yong-gang
Department Of Earth Sciences University Of Southern California
-
Chen Po
Department Of Psychiatry National Cheng Kung University Medical Center
-
COCHRAN Elizabeth
Institute of Geophysics and Planetary Physics, University of California at Los Angeles
-
VIDALE John
Institute of Geophysics and Planetary Physics, University of California at Los Angeles
-
Vidale John
Institute Of Geophysics And Planetary Physics University Of California At Los Angeles
-
Cochran Elizabeth
Institute Of Geophysics And Planetary Physics University Of California At Los Angeles
-
Chen Po
Department Of Psychiatry College Of Medicine National Cheng Kung University
-
Chen Po
Department Of Earth Sciences University Of Southern California
関連論文
- Interleukin-4 Up-Regulates T-Tropic Human Immunodeficiency Virus Type 1 Transcription in Primary CD4^+ CD38^+ T-Lymphocyte Subset
- Human Immunodeficiency Virus Type 1 Subtype C Exhibits Higher Transactivation Actvity of Tat than Subtypes B and E
- Seismic velocity variations on the San Andreas fault caused by the 2004 M6 Parkfield Earthquake and their implications
- The relationship among insight, cognitive function of patients with schizophrenia and their relatives' perception
- The psychological well-being and associated factors of caregivers of outpatients with schizophrenia in Taiwan
- Starvation-induced Wernicke's encephalopathy in schizophrenia
- Correlation between scores on Continuous Performance Test and plasma concentration for schizophrenic patients on risperidone
- Correlation between performance on the Continuous Performance Test and economic costs in patients with schizophrenia
- Two case studies of hypothermia induced by an increased dosage of zotepine in a combination therapy
- Olanzapine in Chinese treatment-resistant patients with schizophrenia : An open-label, prospective trial